Crop Life Science Valuation

Is CLSL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLSL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CLSL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CLSL's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLSL?

Key metric: As CLSL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CLSL. This is calculated by dividing CLSL's market cap by their current earnings.
What is CLSL's PE Ratio?
PE Ratio	13.3x
Earnings	₹60.42m
Market Cap	₹805.58m

CLSL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.6x
Enterprise Value/EBITDA	9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does CLSL's PE Ratio compare to its peers?

The above table shows the PE ratio for CLSL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	24.6x
530883 Super Crop Safe	28.4x	n/a	₹748.8m
ARISTO Aristo Bio-Tech and Lifescience	22.9x	n/a	₹891.1m
542123 Phosphate	27.3x	n/a	₹548.3m
AMBEY Ambey Laboratories	19.8x	n/a	₹1.5b
CLSL Crop Life Science	13.3x	n/a	₹805.6m

Price-To-Earnings vs Peers: CLSL is good value based on its Price-To-Earnings Ratio (13.3x) compared to the peer average (24.6x).

Price to Earnings Ratio vs Industry

How does CLSL's PE Ratio compare vs other companies in the IN Chemicals Industry?

4 Companies	Price / Earnings	Estimated Growth	Market Cap
NAGAFERT Nagarjuna Fertilizers and Chemicals	0.3x	n/a	US$68.07m
526773 Pressure Sensitive Systems (India)	0.7x	n/a	US$8.86m
526143 MPL Plastics	1.7x	n/a	US$1.92m
509910 Southern Gas	0.04x	n/a	US$6.16k

No more companies available in this PE range

4 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: CLSL is good value based on its Price-To-Earnings Ratio (13.3x) compared to the Indian Chemicals industry average (32.4x).

Price to Earnings Ratio vs Fair Ratio

What is CLSL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLSL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	13.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CLSL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

MOIL

₹60.3b

Engages in the exploration, development, and marketing of various grades of manganese ores in India.

533286

₹296.50

-9.0%

10.2%

Vedanta

₹1.7t

A diversified natural resources company, explores, extracts, and processes minerals, and oil and gas in India, Europe, China, the United States, Mexico, and internationally.

500295

₹433.50

-5.3%

81.2%

ACC

₹410.9b

Engages in the manufacture and sale of cement and ready-mix concrete in India.

500410

₹2,187.55

-4.4%

18.3%